The Potential of Angiogenin As a Serum Biomarker for Diseases: Systematic Review and Meta-Analysis

Overview

Journal Dis Markers

Publisher Wiley

Specialty Biochemistry

Date 2018 May 9

PMID 29736193

Citations 23

Authors

Dongdong Yu

Yikai Cai

Wei Zhou

Jinghao Sheng

Zhengping Xu

Affiliations

Soon will be listed here.

Abstract

Background: Angiogenin (ANG) is a multifunctional angiogenic protein that participates in both normal development and diseases. Abnormal serum ANG levels are commonly reported in various diseases. However, whether ANG can serve as a diagnostic or prognostic marker for different diseases remains a matter of debate.

Methods: Here, we performed a systematic review and meta-analysis of the literature utilizing PubMed, Web of Science, and Scopus search engines to identify all publications comparing plasma or serum ANG levels between patients with different diseases and healthy controls, as were studies evaluating circulating ANG levels in healthy populations, pregnant women, or other demographic populations.

Results: This study demonstrated that the serum ANG concentration in healthy populations was 336.14 ± 142.83 ng/ml and remained relatively stable in different populations and regions. We noted no significant differences in serum ANG levels between patients and healthy controls, except in cases in which patients suffered from cancer or cardiovascular diseases. The serum ANG concentrations were significantly higher in patients who developed colorectal cancer, acute myeloid leukemia, multiple myeloma, myelodysplastic syndromes, and heart failure than those in healthy controls.

Conclusion: ANG has the potential of being a serum biomarker for cancers and cardiovascular diseases.

Citing Articles

Assay for ribosome stimulation of angiogenin nuclease activity.

Sholi E, Loveland A, Korostelev A Methods Enzymol. 2025; 711:381-404.

PMID: 39952716 PMC: 11839171. DOI: 10.1016/bs.mie.2024.11.007.

Tumor Cell Survival Factors and Angiogenesis in Chronic Lymphocytic Leukemia: How Hot Is the Link?.

Ayoub M, Susin S, Bauvois B Cancers (Basel). 2025; 17(1.

PMID: 39796700 PMC: 11719013. DOI: 10.3390/cancers17010072.

Ribonuclease inhibitor 1 emerges as a potential biomarker and modulates inflammation and iron homeostasis in sepsis.

Neu C, Beckers C, Frank N, Thomas K, Bartneck M, Simon T Sci Rep. 2024; 14(1):14972.

PMID: 38951571 PMC: 11217267. DOI: 10.1038/s41598-024-65778-8.

Research progress on the structure, function, and use of angiogenin in malignant tumours.

Mao M, Chen W, Ye D Heliyon. 2024; 10(9):e30654.

PMID: 38756602 PMC: 11096933. DOI: 10.1016/j.heliyon.2024.e30654.

Plasma Proteomics of Diabetic Kidney Disease Among Asians With Younger-Onset Type 2 Diabetes.

Gurung R, Zheng H, Koh H, Yiamunaa M, M Y, Liu J J Clin Endocrinol Metab. 2024; 110(2):e239-e248.

PMID: 38626182 PMC: 11747753. DOI: 10.1210/clinem/dgae266.

References

Alexandrakis M, Passam F, Sfiridaki K, Moschandrea J, Pappa C, Liapi D . Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival. Leuk Res. 2003; 28(3):259-66. DOI: 10.1016/s0145-2126(03)00261-3. View

Soukup V, Kalousova M, Capoun O, Sobotka R, Breyl Z, Pesl M . Panel of Urinary Diagnostic Markers for Non-Invasive Detection of Primary and Recurrent Urothelial Urinary Bladder Carcinoma. Urol Int. 2015; 95(1):56-64. DOI: 10.1159/000368166. View

Kieran D, Sebastia J, Greenway M, King M, Connaughton D, Concannon C . Control of motoneuron survival by angiogenin. J Neurosci. 2008; 28(52):14056-61. PMC: 6671464. DOI: 10.1523/JNEUROSCI.3399-08.2008. View

Eissa S, Kenawy G, Swellam M, Abou El-Fadle A, El-Aal A, El-Ahmady O . Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma. Clin Biochem. 2004; 37(9):803-10. DOI: 10.1016/j.clinbiochem.2004.05.027. View

Lewicki L, Siebert J, Marek-Trzonkowska N, Masiewicz E, Kolinski T, Reiwer-Gostomska M . Elevated Serum Tryptase and Endothelin in Patients with ST Segment Elevation Myocardial Infarction: Preliminary Report. Mediators Inflamm. 2015; 2015:395173. PMC: 4452104. DOI: 10.1155/2015/395173. View

Alexandrakis M, Passam F, Pappa C, Sfiridaki K, Tsirakis G, Damilakis J . Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes. Leuk Res. 2004; 29(1):41-6. DOI: 10.1016/j.leukres.2004.05.002. View

Malamitsi-Puchner A, Sarandakou A, Giannaki G, Rizos D, Phocas I . Changes of angiogenin serum concentrations in the perinatal period. Pediatr Res. 1997; 41(6):909-11. DOI: 10.1203/00006450-199706000-00018. View

Hooper L, Stappenbeck T, Hong C, Gordon J . Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol. 2003; 4(3):269-73. DOI: 10.1038/ni888. View

Ugurel S, Rappl G, Tilgen W, Reinhold U . Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol. 2001; 19(2):577-83. DOI: 10.1200/JCO.2001.19.2.577. View

10.

Hisai H, Kato J, Kobune M, Murakami T, Miyanishi K, Takahashi M . Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity. Clin Cancer Res. 2003; 9(13):4852-9. View

11.

Shaarawy M, Al-Sokkary F, Sheba M, Wahba O, Kandil H, Abdel-Mohsen I . Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsia. Int J Gynaecol Obstet. 2005; 88(2):112-7. DOI: 10.1016/j.ijgo.2004.10.005. View

12.

Lee H, Lee I, Kang T, Jeong G, CHANG S . Angiogenin is involved in morphological changes and angiogenesis in the ovary. Biochem Biophys Res Commun. 1999; 257(1):182-6. DOI: 10.1006/bbrc.1999.0359. View

13.

Ilzecka J . Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis. Acta Clin Croat. 2008; 47(2):77-9. View

14.

Malamitsi-Puchner A, Sarandakou A, Dafogianni C, Tziotis J, Bartsocas C . Serum angiogenin levels in children and adolescents with insulin-dependent diabetes mellitus. Pediatr Res. 1998; 43(6):798-800. DOI: 10.1203/00006450-199806000-00013. View

15.

Brunner B, Gunsilius E, Schumacher P, Zwierzina H, Gastl G, Stauder R . Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia. J Hematother Stem Cell Res. 2002; 11(1):119-25. DOI: 10.1089/152581602753448586. View

16.

Kim J, Sohn S, Kim D, Baek J, Lee N, Suh J . Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia. Leuk Lymphoma. 2005; 46(6):885-91. DOI: 10.1080/10428190500054491. View

17.

Tello-Montoliu A, Marin F, Patel J, Roldan V, Mainar L, Vicente V . Plasma angiogenin levels in acute coronary syndromes: implications for prognosis. Eur Heart J. 2007; 28(24):3006-11. DOI: 10.1093/eurheartj/ehm488. View

18.

Kolben M, Blaser J, Ulm K, Schmitt M, Schneider K, Tschesche H . Angiogenin plasma levels during pregnancy. Am J Obstet Gynecol. 1997; 176(1 Pt 1):37-41. DOI: 10.1016/s0002-9378(97)80008-7. View

19.

Yoon B, Oh S, Romero R, Shim S, Han S, Park J . An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol. 2001; 185(5):1162-7. DOI: 10.1067/mob.2001.117678. View

20.

Gui C, Li S, Nong Q, Du F, Zhu L, Zeng Z . Changes of serum angiogenic factors concentrations in patients with diabetes and unstable angina pectoris. Cardiovasc Diabetol. 2013; 12:34. PMC: 3598554. DOI: 10.1186/1475-2840-12-34. View